Halozyme Therapeutics, Inc.
US ˙ NasdaqGS ˙ US40637H1095

Wstęp

Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Helen Torley. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.

Średnia rentowność handlu

Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.

Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.

Częstotliwość aktualizacji: codziennie

Zobacz listę najbardziej dochodowych insiderów.

Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji

Z dokumentów SEC wynika, że Helen Torley zgłosił udziały lub transakcje w następujących spółkach:

Papier wartościowy Nazwa Najnowsze raporty dotyczące udziałów
US:HALO / Halozyme Therapeutics, Inc. PRESIDENT AND CEO, Director 767 780
US:DGX / Quest Diagnostics Incorporated Director 6 260
US:RLYP / Relypsa, Inc. Director 0
US:ONXX / Onyx Pharmaceuticals Inc EVP, Chief Commercial Officer 0
Jak interpretować wykresy

Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Helen Torley. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.

Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.

Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.

Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.

Zakupy insidera HALO / Halozyme Therapeutics, Inc. – krótkoterminowa analiza zysków

W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w HALO / Halozyme Therapeutics, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .

Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.

Data transakcji Ticker Insider Zgłoszone
Akcje
Zgłoszona
Cena
Skorygowane
Akcje
Skorygowana
Cena
Podstawa kalkulacji kosztów Dni do
maks
Cena
maks
Maks
Zysk ($)
Maksymalny zwrot (%)
2014-09-16 HALO Torley Helen 50 000 8,9200 50 000 8,9200 446 000 309 24.7500 791 500 177,47

Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Sprzedaż insidera HALO / Halozyme Therapeutics, Inc. — analiza strat krótkoterminowych

W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w HALO / Halozyme Therapeutics, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .

Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.

Data transakcji Ticker Insider Zgłoszone
Akcje
Zgłoszona
Cena
Skorygowane
Akcje
Skorygowana
Cena
Podstawa kalkulacji kosztów Dni do
min
Cena
min
Uniknięta
maksymalna strata ($)
Uniknięta
Maksymalna strata (%)
2023-02-16 HALO Torley Helen 11 061 49,2600 11 061 49,2600 544 865 81 30.2800 -209 937 -38,53
2020-11-25 HALO Torley Helen 22 326 40,1740 22 326 40,1740 896 925
2020-11-25 HALO Torley Helen 27 674 41,1810 27 674 41,1810 1 139 643

Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Historia handlu insiderów

Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Helen Torley ujawnioną Komisji Papierów Wartościowych (SEC).

Data pliku Data trans Formularz Ticker Bezpieczeństwo Kod 10b5-1 Akcje Pozostałe akcje Zmiana
procent
Cena
udziału
Wartość
trans
Pozostała
Wartość
2026-06-03 2026-06-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6 100 767 780 -0,79 69,69 -425 121 53 508 124
2026-06-03 2026-06-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 000 773 880 -0,26 68,74 -137 472 53 193 416
2026-06-03 2026-06-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 500 775 880 -0,19 67,68 -101 512 52 507 679
2026-06-03 2026-06-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -400 777 380 -0,05 66,37 -26 547 51 593 156
2026-06-03 2026-06-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 777 780 1,30 12,07 120 700 9 387 805
2026-06-03 2026-06-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3 400 767 780 -0,44 66,74 -226 933 51 245 476
2026-06-03 2026-06-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -16 600 771 180 -2,11 66,31 -1 100 812 51 140 031
2026-06-03 2026-06-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 787 780 2,60 12,07 241 400 9 508 505
2026-06-03 2026-06-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5 401 767 780 -0,70 68,35 -369 137 52 474 692
2026-06-03 2026-06-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12 989 773 181 -1,65 67,41 -875 588 52 120 131
2026-06-03 2026-06-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 610 786 170 -0,20 66,39 -106 885 52 192 254
2026-06-03 2026-06-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 787 780 2,60 12,07 241 400 9 508 505
2026-05-13 2026-05-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 767 780 -0,08 70,81 -42 487 54 368 037
2026-05-13 2026-05-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3 950 768 380 -0,51 69,79 -275 659 53 622 935
2026-05-13 2026-05-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3 350 772 330 -0,43 68,88 -230 748 53 198 090
2026-05-13 2026-05-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 100 775 680 -0,27 68,10 -143 014 52 825 359
2026-05-13 2026-05-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 10 000 777 780 1,30 12,07 120 700 9 387 805
2026-05-13 2026-05-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 800 767 780 -0,36 73,12 -204 739 56 140 841
2026-05-13 2026-05-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5 900 770 580 -0,76 72,15 -425 673 55 595 806
2026-05-13 2026-05-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 802 776 480 -1,25 71,37 -699 569 55 417 378
2026-05-13 2026-05-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 398 786 282 -0,18 70,29 -98 261 55 265 403
2026-05-13 2026-05-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 787 680 -0,01 67,85 -6 785 53 444 088
2026-05-13 2026-05-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 787 780 2,60 12,07 241 400 9 508 505
2026-05-13 2026-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6 700 767 780 -0,87 66,33 -444 391 50 924 544
2026-05-13 2026-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3 575 774 480 -0,46 65,46 -234 012 50 695 912
2026-05-13 2026-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 725 778 055 -1,23 64,63 -628 536 50 286 473
2026-05-13 2026-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 787 780 2,60 12,07 241 400 9 508 505
2026-04-07 2026-04-06 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4 100 767 780 -0,53 64,02 -262 462 49 149 437
2026-04-07 2026-04-06 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5 900 771 880 -0,76 63,14 -372 520 48 735 731
2026-04-07 2026-04-06 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 777 780 1,30 12,07 120 700 9 387 805
2026-04-02 2026-04-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4 200 767 780 -0,54 64,89 -272 525 49 818 941
2026-04-02 2026-04-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -15 800 771 980 -2,01 64,06 -1 012 195 49 455 355
2026-04-02 2026-04-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 787 780 2,60 12,07 241 400 9 508 505
2026-04-02 2026-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 000 767 780 -0,13 65,71 -65 714 50 453 895
2026-04-02 2026-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -19 000 768 780 -2,41 65,36 -1 241 802 50 245 923
2026-04-02 2026-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 787 780 2,60 12,07 241 400 9 508 505
2026-03-04 2026-03-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 671 767 780 -0,35 70,94 -189 494 54 470 152
2026-03-04 2026-03-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7 329 770 451 -0,94 69,94 -512 620 53 888 425
2026-03-04 2026-03-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 777 780 1,30 12,07 120 700 9 387 805
2026-03-04 2026-03-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6 519 767 780 -0,84 69,33 -451 982 53 232 491
2026-03-04 2026-03-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -13 481 774 299 -1,71 68,85 -928 167 53 310 486
2026-03-04 2026-03-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 787 780 2,60 12,07 241 400 9 508 505
2026-03-04 2026-03-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -578 767 780 -0,08 70,46 -40 726 54 098 547
2026-03-04 2026-03-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -15 322 768 358 -1,96 69,80 -1 069 460 53 630 620
2026-03-04 2026-03-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4 100 783 680 -0,52 69,20 -283 708 54 228 305
2026-03-04 2026-03-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 787 780 2,60 12,07 241 400 9 508 505
2026-02-24 2026-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -12 104 767 780 -1,55 70,64 -855 027 54 235 979
2026-02-24 2026-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 22 436 779 884 2,96
2026-02-24 2026-02-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -9 040 757 448 -1,18 70,98 -641 659 53 763 659
2026-02-24 2026-02-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 16 757 766 488 2,24
2026-02-17 2026-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -27 605 749 731 -3,55 79,44 -2 192 941 59 558 631
2026-02-17 2026-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 51 171 777 336 7,05
2026-02-17 2026-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -9 104 726 165 -1,24 79,44 -723 222 57 686 548
2026-02-17 2026-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 16 875 735 269 2,35
2026-02-17 2026-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -11 334 718 394 -1,55 79,44 -900 373 57 069 219
2026-02-17 2026-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21 009 729 728 2,96
2026-02-05 2026-02-05 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4 624 708 719 -0,65 78,94 -365 000 55 943 443
2026-02-05 2026-02-05 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5 376 713 343 -0,75 78,38 -421 366 55 911 111
2026-02-05 2026-02-05 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 718 719 1,41 12,07 120 700 8 674 938
2026-02-05 2026-02-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 100 708 719 -1,41 77,54 -783 154 54 954 071
2026-02-05 2026-02-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 900 718 819 -1,36 76,94 -761 666 55 303 059
2026-02-05 2026-02-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 728 719 2,82 12,07 241 400 8 795 638
2026-02-05 2026-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7 790 708 719 -1,09 76,73 -597 758 54 382 844
2026-02-05 2026-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 659 716 509 -1,33 75,94 -733 543 54 414 559
2026-02-05 2026-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 551 726 168 -0,35 74,88 -191 016 54 374 734
2026-02-05 2026-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 728 719 2,82 12,07 241 400 8 795 638
2025-12-01 2025-12-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -261 708 719 -0,04 71,60 -18 688 50 744 280
2025-12-01 2025-12-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -500 708 980 -0,07 70,36 -35 181 49 885 251
2025-12-01 2025-12-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5 402 709 480 -0,76 69,44 -375 120 49 267 001
2025-12-01 2025-12-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 406 714 882 -1,43 68,51 -712 936 48 977 996
2025-12-01 2025-12-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 16 569 725 288 2,34 8,11 134 375 5 882 086
2025-12-01 2025-11-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -25 000 708 719 -3,41
2025-11-12 2025-11-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -498 733 719 -0,07 71,67 -35 690 52 583 440
2025-11-12 2025-11-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6 784 734 217 -0,92 71,09 -482 268 52 194 752
2025-11-12 2025-11-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12 718 741 001 -1,69 70,22 -893 033 52 031 608
2025-11-12 2025-11-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-11-12 2025-11-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11 500 733 719 -1,54 69,73 -801 906 51 162 960
2025-11-12 2025-11-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4 000 745 219 -0,53 68,80 -275 180 51 267 341
2025-11-12 2025-11-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4 500 749 219 -0,60 67,89 -305 514 50 865 976
2025-11-12 2025-11-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-11-12 2025-11-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 733 719 -0,01 69,30 -6 930 50 846 727
2025-11-12 2025-11-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -19 900 733 819 -2,64 68,71 -1 367 409 50 423 639
2025-11-12 2025-11-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-10-03 2025-10-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -724 733 719 -0,10 71,67 -51 891 52 587 108
2025-10-03 2025-10-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 707 734 443 -0,37 70,58 -191 065 51 838 456
2025-10-03 2025-10-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 334 737 150 -0,32 69,83 -162 983 51 475 184
2025-10-03 2025-10-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -14 235 739 484 -1,89 68,47 -974 699 50 633 948
2025-10-03 2025-10-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-10-03 2025-10-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 733 719 -0,01 74,66 -7 466 54 783 129
2025-10-03 2025-10-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -700 733 819 -0,10 73,24 -51 265 53 741 968
2025-10-03 2025-10-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 400 734 519 -0,33 72,06 -172 956 52 933 112
2025-10-03 2025-10-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 200 736 919 -1,37 71,28 -727 036 52 526 112
2025-10-03 2025-10-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6 600 747 119 -0,88 70,51 -465 359 52 678 614
2025-10-03 2025-10-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-10-03 2025-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8 295 733 719 -1,12 75,69 -627 873 55 537 392
2025-10-03 2025-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11 705 742 014 -1,55 75,11 -879 151 55 731 930
2025-10-03 2025-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-09-04 2025-09-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 300 733 719 -0,31 75,22 -173 015 55 193 278
2025-09-04 2025-09-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7 800 736 019 -1,05 74,33 -579 751 54 706 084
2025-09-04 2025-09-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 900 743 819 -1,31 73,54 -728 006 54 697 474
2025-09-04 2025-09-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-09-04 2025-09-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 500 733 719 -1,41 74,63 -783 636 54 758 916
2025-09-04 2025-09-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 500 744 219 -1,26 74,22 -705 090 55 235 934
2025-09-04 2025-09-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-09-04 2025-09-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3 412 733 719 -0,46 74,15 -252 990 54 403 063
2025-09-04 2025-09-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -16 288 737 131 -2,16 73,70 -1 200 393 54 325 080
2025-09-04 2025-09-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -300 753 419 -0,04 72,48 -21 746 54 611 576
2025-09-04 2025-09-02 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-08-13 2025-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5 052 733 719 -0,68 64,83 -327 511 47 565 535
2025-08-13 2025-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -14 948 738 771 -1,98 64,14 -958 839 47 388 466
2025-08-13 2025-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-08-13 2025-08-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6 958 733 719 -0,94 64,00 -445 319 46 958 750
2025-08-13 2025-08-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -13 042 740 677 -1,73 63,24 -824 802 46 841 895
2025-08-13 2025-08-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-08-13 2025-08-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 283 733 719 -0,17 63,60 -81 596 46 663 061
2025-08-13 2025-08-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -18 717 735 002 -2,48 63,01 -1 179 321 46 311 006
2025-08-13 2025-08-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-07-10 2025-07-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -15 746 733 719 -2,10 57,62 -907 237 42 274 688
2025-07-10 2025-07-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4 254 749 465 -0,56 56,74 -241 380 42 526 143
2025-07-10 2025-07-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-07-10 2025-07-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -208 733 719 -0,03 57,08 -11 872 41 877 746
2025-07-10 2025-07-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -19 792 733 927 -2,63 56,43 -1 116 783 41 412 565
2025-07-10 2025-07-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-07-10 2025-07-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -16 402 733 719 -2,19 55,74 -914 215 40 896 030
2025-07-10 2025-07-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3 598 750 121 -0,48 54,48 -196 030 40 868 842
2025-07-10 2025-07-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-06-24 2025-06-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -15 511 733 719 -2,07 53,91 -836 214 39 555 525
2025-06-24 2025-06-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4 489 749 230 -0,60 53,11 -238 406 39 790 856
2025-06-24 2025-06-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-06-24 2025-06-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -20 000 733 719 -2,65 52,57 -1 051 460 38 573 809
2025-06-24 2025-06-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-06-24 2025-06-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -20 000 733 719 -2,65 52,96 -1 059 200 38 857 758
2025-06-24 2025-06-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 20 000 753 719 2,73 8,11 162 200 6 112 661
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -12 081 733 719 -1,62 57,75 -697 678 42 372 272
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 22 436 745 800 3,10
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -9 087 723 364 -1,24 58,29 -529 681 42 164 888
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 16 875 732 451 2,36
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -11 313 715 576 -1,56 58,29 -659 435 41 710 925
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21 009 726 889 2,98
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -38 668 705 880 -5,19 58,29 -2 253 958 41 145 745
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 71 810 744 548 10,67
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -7 098 672 738 -1,04 58,29 -413 742 39 213 898
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 13 092 679 836 1,96
2024-12-03 2024-11-29 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -10 000 666 744 -1,48
2024-10-09 2024-10-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2 404 676 744 -0,35 53,91 -129 590 36 480 562
2024-10-09 2024-10-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 615 679 148 -0,24 53,31 -86 096 36 205 380
2024-10-09 2024-10-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5 981 680 763 -0,87 51,85 -310 097 35 295 519
2024-10-09 2024-10-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-10-09 2024-10-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -900 676 744 -0,13 54,57 -49 116 36 931 950
2024-10-09 2024-10-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 100 677 644 -1,33 53,94 -490 845 36 551 440
2024-10-09 2024-10-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-09-26 2024-09-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 676 744 -1,46 56,10 -560 970 37 963 308
2024-09-26 2024-09-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-09-26 2024-09-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 676 744 -1,46 56,34 -563 370 38 125 727
2024-09-26 2024-09-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-09-26 2024-09-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 676 744 -1,46 58,21 -582 100 39 393 268
2024-09-26 2024-09-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-09-12 2024-09-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 676 744 -1,46 59,20 -592 030 40 065 275
2024-09-12 2024-09-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-09-12 2024-09-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 676 744 -1,46 59,09 -590 870 39 986 773
2024-09-12 2024-09-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-09-12 2024-09-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 676 744 -1,46 59,09 -590 890 39 988 126
2024-09-12 2024-09-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-08-15 2024-08-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 676 744 -1,46 57,95 -579 490 39 216 638
2024-08-15 2024-08-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-08-15 2024-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -200 676 744 -0,03 58,17 -11 634 39 366 198
2024-08-15 2024-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6 537 676 944 -0,96 57,73 -377 394 39 081 331
2024-08-15 2024-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3 263 683 481 -0,48 56,22 -183 443 38 424 618
2024-08-15 2024-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-08-15 2024-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 676 744 -1,46 56,25 -562 490 38 066 173
2024-08-15 2024-08-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 686 744 1,48 13,87 138 700 9 525 139
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -9 070 676 744 -1,32 36,10 -327 427 24 430 458
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 16 875 685 814 2,52
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -11 292 668 939 -1,66 36,10 -407 641 24 148 698
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21 009 680 231 3,19
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -17 619 659 222 -2,60 35,91 -632 698 23 672 662
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
A - Award 32 781 676 841 5,09
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -7 036 644 060 -1,08 35,91 -252 663 23 128 195
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 13 092 651 096 2,05
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16 943 638 004 -2,59 35,49 -601 307 22 642 762
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 31 281 654 947 5,02
2023-08-31 2023-08-31 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 42,82 -428 170 26 703 507
2023-08-31 2023-08-31 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 13,87 138 700 8 788 947
2023-08-31 2023-08-30 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 42,85 -428 540 26 726 583
2023-08-31 2023-08-30 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 13,87 138 700 8 788 947
2023-08-31 2023-08-29 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 42,40 -424 020 26 444 686
2023-08-31 2023-08-29 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 13,87 138 700 8 788 947
2023-08-17 2023-08-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 43,18 -431 820 26 931 145
2023-08-17 2023-08-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 13,87 138 700 8 788 947
2023-08-17 2023-08-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 43,53 -435 320 27 149 428
2023-08-17 2023-08-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 13,87 138 700 8 788 947
2023-08-17 2023-08-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 43,77 -437 680 27 296 613
2023-08-17 2023-08-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 13,87 138 700 8 788 947
2023-07-27 2023-07-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 43,79 -437 900 27 310 334
2023-07-27 2023-07-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 13,87 138 700 8 788 947
2023-07-27 2023-07-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 42,69 -426 890 26 623 678
2023-07-27 2023-07-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 13,87 138 700 8 788 947
2023-07-27 2023-07-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 42,80 -427 960 26 690 410
2023-07-27 2023-07-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 13,87 138 700 8 788 947
2023-03-09 2023-03-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 42,73 -427 270 26 647 377
2023-03-09 2023-03-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 14,66 146 600 9 289 544
2023-03-09 2023-03-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 43,26 -432 590 26 979 167
2023-03-09 2023-03-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 14,66 146 600 9 289 544
2023-03-09 2023-03-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 623 666 -1,58 45,47 -454 690 28 357 469
2023-03-09 2023-03-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 633 666 1,60 14,66 146 600 9 289 544
2023-03-01 2023-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -10 000 623 666 -1,58
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -11 061 633 666 -1,72 49,26 -544 865 31 214 387
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21 010 644 727 3,37
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -6 892 623 717 -1,09 49,20 -339 086 30 686 876
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 13 092 630 609 2,12
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -17 266 617 517 -2,72 48,92 -844 653 30 208 932
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 32 794 634 783 5,45
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16 469 601 989 -2,66 48,92 -805 663 29 449 302
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 31 281 618 458 5,33
2023-02-09 2023-02-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 587 177 -1,67 50,40 -504 000 29 593 721
2023-02-09 2023-02-09 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2023-02-09 2023-02-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 587 177 -1,67 51,36 -513 570 30 155 649
2023-02-09 2023-02-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2023-02-09 2023-02-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 587 177 -1,67 51,26 -512 580 30 097 519
2023-02-09 2023-02-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2023-01-19 2023-01-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 587 177 -1,67 52,41 -524 140 30 776 295
2023-01-19 2023-01-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2023-01-19 2023-01-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 587 177 -1,67 51,05 -510 470 29 973 624
2023-01-19 2023-01-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2023-01-19 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 103 587 177 -0,19 50,93 -56 175 29 904 337
2023-01-19 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8 897 588 280 -1,49 50,40 -448 364 29 646 371
2023-01-19 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2022-12-15 2022-12-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -896 587 177 -0,15 58,20 -52 145 34 171 940
2022-12-15 2022-12-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 104 588 073 -1,52 57,29 -521 550 33 689 526
2022-12-15 2022-12-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2022-12-15 2022-12-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 587 177 -1,67 58,30 -582 980 34 231 245
2022-12-15 2022-12-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2022-12-15 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -493 587 177 -0,08 59,12 -29 146 34 713 904
2022-12-15 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 507 587 670 -1,59 58,64 -557 481 34 460 381
2022-12-15 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2022-11-17 2022-11-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 587 177 -1,67 52,15 -521 490 30 620 693
2022-11-17 2022-11-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2022-11-17 2022-11-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10 000 587 177 -1,67 53,90 -538 990 31 648 253
2022-11-17 2022-11-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2022-11-17 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -13 587 177 0,00 54,60 -710 32 062 800
2022-11-17 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9 987 587 190 -1,67 54,11 -540 437 31 775 200
2022-11-17 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10 000 597 177 1,70 14,66 146 600 8 754 615
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 84 037 84 037
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 257 046 257 046
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -13 092 39 276 -25,00
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -6 892 587 177 -1,16 34,43 -237 292 20 216 504
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 13 092 594 069 2,25
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -28 729 0 -100,00
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -15 125 580 977 -2,54 33,64 -508 805 19 544 066
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28 729 596 102 5,06
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -32 795 32 794 -50,00
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -17 266 567 373 -2,95 34,20 -590 497 19 404 157
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 32 795 584 639 5,94
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -31 282 62 562 -33,33
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16 598 551 844 -2,92 34,94 -579 934 19 281 429
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 31 282 568 442 5,82
2021-11-08 2021-11-08 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise X -50 000 150 000 -25,00 14,66 -733 000 2 199 000
2021-11-08 2021-11-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12 225 537 160 -2,23 40,42 -494 122 21 711 470
2021-11-08 2021-11-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -37 775 549 385 -6,43 39,62 -1 496 646 21 766 634
2021-11-08 2021-11-08 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 587 160 9,31 14,66 733 000 8 607 766
2021-10-04 2021-10-04 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise X -50 000 200 000 -20,00 14,66 -733 000 2 932 000
2021-10-04 2021-10-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5 857 537 160 -1,08 40,95 -239 862 21 998 313
2021-10-04 2021-10-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -44 143 543 017 -7,52 39,97 -1 764 528 21 706 019
2021-10-04 2021-10-04 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 587 160 9,31 14,66 733 000 8 607 766
2021-09-07 2021-09-07 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise X -50 000 250 000 -16,67 14,66 -733 000 3 665 000
2021-09-07 2021-09-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6 560 537 160 -1,21 42,98 -281 942 23 086 600
2021-09-07 2021-09-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -43 440 543 720 -7,40 42,29 -1 836 904 22 991 744
2021-09-07 2021-09-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 587 160 9,31 14,66 733 000 8 607 766
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise X -50 000 300 000 -14,29 14,66 -733 000 4 398 000
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 048 537 160 -0,19 46,11 -48 323 24 768 448
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -500 538 208 -0,09 44,91 -22 454 24 169 845
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -400 538 708 -0,07 43,26 -17 304 23 304 508
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 000 539 108 -0,19 42,64 -42 640 22 987 565
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -21 914 540 108 -3,90 41,47 -908 752 22 397 739
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -25 138 562 022 -4,28 40,42 -1 016 103 22 717 491
2021-08-10 2021-08-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 587 160 9,31 14,66 733 000 8 607 766
2021-07-06 2021-07-06 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50 000 350 000 -12,50 14,66 -733 000 5 131 000
2021-07-06 2021-07-06 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -50 000 537 160 -8,52 45,97 -2 298 650 24 694 857
2021-07-06 2021-07-06 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 587 160 9,31 14,66 733 000 8 607 766
2021-06-07 2021-06-07 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50 000 400 000 -11,11 14,66 -733 000 5 864 000
2021-06-07 2021-06-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -50 000 537 160 -8,52 39,66 -1 982 950 21 303 228
2021-06-07 2021-06-07 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 587 160 9,31 14,66 733 000 8 607 766
2021-05-25 2021-05-25 4 DGX QUEST DIAGNOSTICS INC
Common Stock
A - Award 1 363 6 260 27,83
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50 000 450 000 -10,00 14,66 -733 000 6 597 000
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1 066 537 160 -0,20 44,84 -47 803 24 087 866
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3 956 538 226 -0,73 44,10 -174 479 23 738 458
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -36 522 542 182 -6,31 43,05 -1 572 236 23 340 393
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8 456 578 704 -1,44 42,17 -356 581 24 403 369
2021-05-11 2021-05-11 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 587 160 9,31 14,66 733 000 8 607 766
2021-04-05 2021-04-05 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50 000 500 000 -9,09 14,66 -733 000 7 330 000
2021-04-05 2021-04-05 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -50 000 537 160 -8,52 42,54 -2 127 250 22 853 472
2021-04-05 2021-04-05 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 587 160 9,31 14,66 733 000 8 607 766
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50 000 550 000 -8,33 14,66 -733 000 8 063 000
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -33 890 537 160 -5,93 46,48 -1 575 112 24 965 693
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -16 110 571 050 -2,74 45,58 -734 342 26 030 172
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 587 160 9,31 14,66 733 000 8 607 766
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -39 354 0 -100,00
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -19 511 537 160 -3,50 48,69 -949 991 26 154 320
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 39 354 556 671 7,61
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 52 368 52 368
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 90 134 90 134
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -28 729 28 729 -50,00
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -14 243 517 317 -2,68 49,84 -709 871 25 783 079
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28 729 531 560 5,71
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -32 795 65 589 -33,33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16 259 502 831 -3,13 49,84 -810 349 25 061 097
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 32 795 519 090 6,74
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -31 282 93 844 -25,00
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -15 509 486 295 -3,09 50,60 -784 755 24 606 527
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 31 282 501 804 6,65
2021-02-01 2021-02-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50 000 600 000 -7,69 14,66 -733 000 8 796 000
2021-02-01 2021-02-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5 437 470 522 -1,14 48,51 -263 736 22 823 893
2021-02-01 2021-02-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -44 563 475 959 -8,56 47,76 -2 128 182 22 730 231
2021-02-01 2021-02-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 50 000 520 522 10,63 14,66 733 000 7 630 853
2020-11-30 2020-11-30 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -10 000 470 522 -2,08
2020-11-25 2020-11-25 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -50 000 650 000 -7,14 14,66 -733 000 9 529 000
2020-11-25 2020-11-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -27 674 480 522 -5,45 41,18 -1 139 643 19 788 376
2020-11-25 2020-11-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -22 326 508 196 -4,21 40,17 -896 925 20 416 266
2020-11-25 2020-11-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 50 000 530 522 10,41 14,66 733 000 7 777 453
2020-08-14 2020-08-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -10 000 480 522 -2,04
2020-05-21 2020-05-19 4 DGX QUEST DIAGNOSTICS INC
Common Stock
A - Award 1 531 4 897 45,48
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -39 354 39 354 -50,00
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -19 511 490 522 -3,83 21,83 -425 925 10 708 095
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 39 354 510 033 8,36
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -28 730 57 458 -33,33
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -14 244 470 679 -2,94 21,10 -300 548 9 931 327
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28 730 484 923 6,30
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -32 795 98 384 -25,00
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -16 259 456 193 -3,44 20,00 -325 180 9 123 860
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 32 795 472 452 7,46
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 125 126 125 126
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 266 051 266 051
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -55 487 0 -100,00
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -19 910 439 657 -4,33 19,21 -382 471 8 445 811
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 55 487 459 567 13,73
2020-02-04 2019-12-19 5 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
G - Gift -12 500 404 080 -3,00
2019-05-16 2019-05-14 4 DGX QUEST DIAGNOSTICS INC
Common Stock
A - Award 1 722 3 366 104,74
2019-02-22 2019-02-22 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -39 354 78 708 -33,33
2019-02-22 2019-02-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -19 511 416 580 -4,47 16,81 -327 980 7 002 710
2019-02-22 2019-02-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 39 354 436 091 9,92
2019-02-15 2019-02-14 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -28 730 86 188 -25,00
2019-02-15 2019-02-14 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -14 244 396 737 -3,47 16,54 -235 596 6 562 030
2019-02-15 2019-02-14 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 28 730 410 981 7,52
2019-02-14 2019-02-12 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 131 179 131 179
2019-02-14 2019-02-12 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 250 218 250 218
2019-02-06 2019-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -31 250 0 -100,00
2019-02-06 2019-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -14 547 382 251 -3,67 16,73 -243 371 6 395 059
2019-02-06 2019-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 31 250 396 798 8,55
2019-02-05 2019-02-03 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -55 487 55 487 -50,00
2019-02-05 2019-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -19 425 365 548 -5,05 16,12 -313 131 5 892 634
2019-02-05 2019-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 55 487 384 973 16,84
2018-10-03 2018-10-01 4 DGX QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy)
A - Award 1 298 1 298
2018-07-05 2018-07-02 4 DGX QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy)
A - Award 1 297 1 297
2018-06-05 2018-06-01 4 DGX QUEST DIAGNOSTICS INC
Non-Qualifed Stock Option (right to buy)
A - Award 665 665
2018-05-17 2018-05-15 4 DGX QUEST DIAGNOSTICS INC
Common Stock
A - Award 1 644 1 644
2018-02-23 2018-02-22 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -39 354 118 062 -25,00
2018-02-23 2018-02-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -19 511 329 486 -5,59 19,28 -376 172 6 352 490
2018-02-23 2018-02-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 39 354 348 997 12,71
2018-02-16 2018-02-14 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 114 918 114 918
2018-02-16 2018-02-14 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 201 552 201 552
2018-02-06 2018-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -31 250 31 250 -50,00
2018-02-06 2018-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -15 493 309 643 -4,77 18,25 -282 747 5 650 985
2018-02-06 2018-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 31 250 325 136 10,63
2018-02-05 2018-02-03 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -55 487 110 974 -33,33
2018-02-05 2018-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -24 111 293 886 -7,58 18,37 -442 919 5 398 686
2018-02-05 2018-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 55 487 317 997 21,14
2018-01-09 2018-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -30 000 0 -100,00
2018-01-09 2018-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -11 649 262 510 -4,25 19,46 -226 690 5 108 445
2018-01-09 2018-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 30 000 274 159 12,29
2017-02-24 2017-02-22 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 157 416 157 416
2017-02-24 2017-02-22 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 251 923 251 923
2017-02-07 2017-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -31 250 62 500 -33,33
2017-02-07 2017-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 31 250 244 159 14,68
2017-02-06 2017-02-03 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -55 487 166 461 -25,00
2017-02-06 2017-02-03 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 55 487 212 909 35,25
2017-01-09 2017-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -30 000 30 000 -50,00
2017-01-09 2017-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 30 000 157 422 23,54
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -4 500 0 -100,00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -4 500 0 -100,00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
D - Sale to Issuer -12 000 0 -100,00
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Common Stock
D - Sale to Issuer -2 250 0 -100,00 32,00 -72 000
2016-09-02 2016-09-01 4 RLYP Relypsa Inc
Common Stock
U - Other -1 237 2 250 -35,47 32,00 -39 584 72 000
2016-07-05 2016-06-30 4 HALO HALOZYME THERAPEUTICS INC
Performance Stock Units
M - Exercise -13 500 0 -100,00
2016-07-05 2016-06-30 4 HALO HALOZYME THERAPEUTICS INC
Performance Stock Units
A - Award 13 500 13 500
2016-07-05 2016-06-30 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -7 044 127 422 -5,24 8,63 -60 790 1 099 652
2016-07-05 2016-06-30 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 13 500 134 466 11,16
2016-06-23 2016-06-21 4 RLYP Relypsa Inc
Stock Option (Right to Buy)
A - Award 4 500 4 500
2016-06-23 2016-06-21 4 RLYP Relypsa Inc
Common Stock
A - Award 2 250 3 487 181,89
2016-06-08 2016-06-07 4 RLYP Relypsa Inc
Common Stock
S - Sale -1 013 1 237 -45,02 19,32 -19 570 23 897
2016-02-09 2016-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -31 250 93 750 -25,00
2016-02-09 2016-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -11 743 120 966 -8,85 7,90 -92 770 955 631
2016-02-09 2016-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 31 250 132 709 30,80
2016-02-04 2016-02-03 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 221 948 221 948
2016-02-04 2016-02-03 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 376 569 376 569
2016-01-07 2016-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -30 000 60 000 -33,33
2016-01-07 2016-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -11 686 101 459 -10,33 15,77 -184 288 1 600 008
2016-01-07 2016-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 30 000 113 145 36,08
2016-01-04 2015-12-31 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -16 436 83 145 -16,51 17,33 -284 836 1 440 903
2016-01-04 2015-12-31 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
A - Award 31 500 99 581 46,27
2015-06-08 2015-06-04 4 RLYP Relypsa Inc
Stock Option (right to buy)
A - Award 4 500 4 500
2015-06-08 2015-06-04 4 RLYP Relypsa Inc
Common Stock
A - Award 2 250 2 250
2015-02-06 2015-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 125 000 125 000
2015-02-06 2015-02-06 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 200 000 200 000
2015-01-26 2015-01-22 4 RLYP Relypsa Inc
Stock Option (right to buy)
A - Award 12 000 12 000
2015-01-06 2015-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -30 000 90 000 -25,00
2015-01-06 2015-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -11 919 68 081 -14,90 10,06 -119 905 684 895
2015-01-06 2015-01-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 30 000 80 000 60,00
2014-09-16 2014-09-16 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
P - Purchase 50 000 50 000 8,92 446 000 446 000
2014-01-08 2014-01-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 120 000 120 000
2014-01-08 2014-01-06 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 700 000 700 000 14,66 10 262 000 10 262 000
2014-01-08 3 HALO HALOZYME THERAPEUTICS INC
Common Stock
0
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -24 300 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -12 156 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -1 144 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -44 132 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -11 868 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -28 575 0 -100,00 125,00 -3 571 875
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
U - Other -7 336 28 575 -20,43 125,00 -917 000 3 571 875
2013-09-05 2013-09-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
F - Taxes X -2 099 35 911 -5,52 123,62 -259 478 4 439 318
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1 250 13 300 -8,59
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -7 000 56 000 -11,11
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1 061 46 585 -2,23 126,92 -134 667 5 912 801
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8 250 47 646 -14,76 126,89 -1 046 810 6 045 615
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 1 250 55 896 2,29 37,68 47 100 2 106 161
2013-08-14 2013-08-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 7 000 54 646 14,69 33,70 235 900 1 841 570
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1 250 14 450 -7,96
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -7 000 63 000 -10,00
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1 000 47 646 -2,06 97,26 -97 260 4 634 055
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -2 500 48 646 -4,89 98,28 -245 690 4 780 739
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -3 000 51 146 -5,54 98,78 -296 352 5 052 406
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1 750 54 146 -3,13 97,32 -170 308 5 269 413
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 7 000 55 896 14,32 33,70 235 900 1 883 695
2013-05-15 2013-05-13 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 1 250 48 896 2,62 37,68 47 100 1 842 401
2013-04-03 2013-04-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -466 47 646 -0,97 86,14 -40 141 4 104 226
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24 300 24 300
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 8 600 48 112 21,77
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1 250 15 800 -7,33
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -7 000 70 000 -9,09
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8 250 39 512 -17,27 78,61 -648 532 3 106 038
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 1 250 47 762 2,69 37,68 47 100 1 799 672
2013-02-06 2013-02-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 7 000 46 512 17,72 33,70 235 900 1 567 454
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -1 250 17 050 -6,83
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -7 000 77 000 -8,33
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -11 997 39 512 -23,29 75,22 -902 414 2 972 093
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 1 250 51 509 2,49 37,68 47 100 1 940 859
2012-11-30 2012-11-12 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 7 000 50 259 16,18 33,70 235 900 1 693 728
2012-10-05 2012-10-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -2 314 43 259 -5,08 86,51 -200 184 3 742 336
2012-09-06 2012-09-04 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1 878 56 823 -3,20 72,78 -136 681 4 135 578
2012-08-08 2012-08-06 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale -2 000 58 701 -3,29 71,89 -143 780 4 220 015
2012-07-27 2012-07-25 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -4 549 60 701 -6,97 73,97 -336 498 4 490 168
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 18 300 18 300
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 17 150 65 250 35,65
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 3 600 48 100 8,09
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)